Skip to content

Clinical trials

Phase 3 Heart Failure trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 3 Country / region: Germany Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20051
20063
20073
20084
20092
20101
20113
20133
20144
20152
20163
20177
20185
20193
20202
20221
20231
20246
20255
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Recruiting13
Terminated11
Active, not recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals10
Boehringer Ingelheim7
AstraZeneca5
Bayer3
Novo Nordisk A/S3
Amgen2
Cytokinetics2
Janssen Research & Development, LLC2
Lexicon Pharmaceuticals2
LivaNova2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure67
Cardiovascular Diseases5
Hypertension5
Myocardial Infarction4
Ventricular Dysfunction, Left4
Renal Insufficiency, Chronic3
Stroke3
Anemia2
Aortic Valve Stenosis2
Coronary Artery Disease2

Trials

Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.